4P-Pharma est dans le dossier Spécial Biotech du journal Le Point. Un grand merci à la SATT Lutech du Réseau SATT pour notre partenariat autour de 4P-004 une molécule pour combattre l’arthrose.
A consulter en ligne ici : https://partenaires.lepoint.fr/special-biotech/4p-pharma#
Revital Rattenbach, our CEO, will be attending the upcoming Human Biotech & Animal Health Business Partnering Summit in Boston, April 9th 2019.
Contact us to schedule a meeting and discuss future collaborations.
4P-Pharma team wishes you a happy holidays season. We believe that with hard work, imagination and a strong team spirit everything is achievable, and the dream that you were pursuing becomes right there for you to grab!
Cheers!
4P-Pharma Team will be attending the upcoming Biofit 2018 conference in Lille December 4-5th. To learn more about possible partnerships, co-development and our pipeline, contact us via the partnering platform or get in touch with our Business Developer Roselina Lam at roselina(at)4p-pharma.com.
Looking forward to meet you there!
Our collaboration with Elsevier’s The Hive program continues with a new blog post entry! In our previous blog post we detailed how Elsevier’s suite of R&D solutions have been helping us in boosting our Research (Read it here). This time we focus on our business model of partnerships and co-development to detect and develop promising technologies in the field of cancer and inflammatory diseases.
Read our latest blog post: https://pharma.elsevier.com/pharma-rd/leveraging-partnerships-rescue-develop-promising-technologies/
Les 4 et 5 octobre derniers se tenait au Palais Brogniart l’édition 2018 de Parcours France, l’événement incontournable de l’économie et business en régions.
A cette occasion, Revital Rattenbach, CEO 4P-Pharma, est intervenue lors d’une table ronde organisée en partenariat avec France Biotech sur le thème ” Biotech en France, un succès possible grâce aux clusters d’innovation locaux”
Retrouvez le compte-rendu de cette table ronde sur le site de Parcours France:
